Drug May Extend Life When Breast Cancer Spreads
... -- A new study affirms that the chemotherapy drug abraxane is more effective, with less troublesome side effe...tic breast cancer. When compared with Taxotere, abraxane extended the time before a recurrence by almost se...een presented at national meetings, reaffirms that abraxane is a very active drug, is well-tolerated and appea...NYU Langone Medical Center's tip sheet to the 44th annual meeting of ASCO
...the feasibility and efficacy of the triple combination of oblimersen (OBL), abraxane (ABX), and temozolomide (TMZ) in metastatic melanoma and normal LDH NYU C...with metastatic melanoma received a therapy that combined oblimersen (OBL), abraxane (ABX) and temozolomide (TMZ). All 14 enrolled patients belonging to the fir...Study looks at new bladder cancer therapy for patients unresponsive to standard treatment
...nter are investigating an FDA-approved metastatic breast-cancer drug called abraxane that may prove a safe and effective alternative to surgery for these patien...inistration at higher concentrations," says Dr. McKiernan. "In one study of abraxane for metastatic breast cancer, the drug successfully shrank tumors and had f...2 new therapies show promise for cancer patients
... The fact that we saw this kind of activity in a phase I trial is dramatic, Von Hoff said. The rationale behind the combination of Gemcitabine plus abraxane was based on careful science and was designed and executed by some of the leading experts in pancreas cancer in the world. While the data is prelimina...Nanoparticle Breast Cancer Drug Approved by FDA
...t role in Food and Drug Administration approval of abraxane (paclitaxel protein-bound particles for injectable...the more common treatments showed improvement with abraxane and experienced less-severe side effects that made treatment more tolerable," Gradishar said. abraxane is engineered using a proprietary process (protein...Midwest large cap life science group strengthening in the third quarter
...l listing price on the NYSE. American Pharmaceutical Partners has also been on a roll ever since new CEO Al Heller took charge and its new cancer drug abraxane was approved by the FDA and has launched. A number of companies continued to suffer during the year including Abbott and Eli Lilly. Abbott was se...